Search Results - Alessandra Tedeschi
- Showing 1 - 20 results of 53
- Go to Next Page
-
1
-
2
-
3
-
4
Phase II study of cladribine and cyclophosphamide in patients with chronic lymphocytic leukemia and prolymphocytic leukemia by Marco Montillo, Alessandra Tedeschi, Susan O’Brien, Francesco Di Raimondo, Susan Lerner, Alessandra Ferrajoli, Enrica Morra, Michael J. Keating
Published 2002Artigo -
5
Waldenström’s macroglobulinaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up by Efstathios Kastritis, V. Leblond, Meletios Α. Dimopoulos, Eva Kimby, Philipp B. Staber, Marie José Kersten, Alessandra Tedeschi, Christian Buske
Published 2018Artigo -
6
-
7
Fludarabine, cytarabine, and G-CSF (FLAG) for the treatment of poor risk acute myeloid leukemia by Marco Montillo, Salvatore Mirto, Maria Concetta Petti, Roberto Latagliata, Silvana Magrin, António E. Pinto, Vittorina Zagonel, Giuseppina Mele, Alessandra Tedeschi, Felicetto Ferrara
Published 1998Artigo -
8
Zanubrutinib, Alone and in Combination With Tislelizumab, for the Treatment of Richter Transformation of Chronic Lymphocytic Leukemia by Constantine S. Tam, Javier Muñoz, Gavin Cull, Stephen Opat, Heather Allewelt, Xiaoping Zhang, J. C. Stern, James Hilger, Kunthel By, Aileen Cohen, Alessandra Tedeschi
Published 2023Artigo -
9
Risk of second cancers in Waldenström macroglobulinemia by Marzia Varettoni, Alessandra Tedeschi, Luca Arcaini, Cristiana Pascutto, Eleonora Vismara, Ester Orlandi, Francesca Ricci, Alessandro Corso, Antonio Greco, Silvia Mangiacavalli, Mario Lazzarino, Enrica Morra
Published 2011Artigo -
10
Alemtuzumab As Consolidation After a Response to Fludarabine Is Effective in Purging Residual Disease in Patients With Chronic Lymphocytic Leukemia by Marco Montillo, Alessandra Tedeschi, Sara Miqueleiz, Silvio Veronese, Roberto Cairoli, Liliana Intropido, Francesca Ricci, Anna Colosimo, Barbara Scarpati, Michela Montagna, Michele Nichelatti, Mario Regazzi, Enrica Morra
Published 2006Artigo -
11
Primary therapy of Waldenström macroglobulinemia (WM) with weekly bortezomib, low-dose dexamethasone, and rituximab (BDR): long-term results of a phase 2 study of the European Myel... by Meletios Α. Dimopoulos, Ramón García‐Sánz, Maria Gavriatopoulou, Pierre Morel, Marie-Christine Kyrtsonis, Eurydiki Michalis, Zafiris Kartasis, Xavier Leleu, Giovanni Palladini, Alessandra Tedeschi, Dimitra Gika, Giampaolo Merlini, Efstathios Kastritis, Pieter Sonneveld
Published 2013Artigo -
12
BDR in newly diagnosed patients with WM: final analysis of a phase 2 study after a minimum follow-up of 6 years by Maria Gavriatopoulou, Ramón García‐Sánz, Efstathios Kastritis, Pierre Morel, Marie-Christine Kyrtsonis, Eurydiki Michalis, Zafiris Kartasis, Xavier Leleu, Giovanni Palladini, Alessandra Tedeschi, Dimitra Gika, Giampaolo Merlini, Pieter Sonneveld, Meletios Α. Dimopoulos
Published 2016Artigo -
13
Zanubrutinib monotherapy in relapsed/refractory indolent non-Hodgkin lymphoma by Tycel Phillips, Henry Chan, Constantine S. Tam, Alessandra Tedeschi, Patrick B. Johnston, Sung Yong Oh, Stephen Opat, Hyeon‐Seok Eom, Heather Allewelt, J. C. Stern, Ziwen Tan, William Novotny, Jane Huang, Judith Trotman
Published 2022Artigo -
14
First-line treatment of chronic lymphocytic leukemia with ibrutinib plus obinutuzumab <i>versus</i> chlorambucil plus obinutuzumab: final analysis of the randomized, ph... by Carol Moreno, Richard Greil, Fatih Demırkan, Alessandra Tedeschi, Bertrand Anz, Loree Larratt, Martin Šimkovič, Jan Novák, Владимир Стругов, Devinder Gill, John G. Gribben, Kevin Kwei, Sandra Dai, Emily Hsu, James P. Dean, Ian W. Flinn
Published 2022Artigo -
15
Ibrutinib in previously treated chronic lymphocytic leukemia patients with autoimmune cytopenias in the RESONATE study by Marco Montillo, Susan O’Brien, Alessandra Tedeschi, John C. Byrd, Claire Dearden, Devinder Gill, Jennifer R. Brown, Jacqueline C. Barrientos, Stephen P. Mulligan, Richard R. Furman, Florence Cymbalista, Clara Plascencia, S. Chang, Emily Hsu, Danelle F. James, Peter Hillmen
Published 2017Carta -
16
Zanubrutinib for the treatment of patients with Waldenström macroglobulinemia: 3 years of follow-up by Judith Trotman, Stephen Opat, David Gottlieb, David Simpson, Paula Marlton, Gavin Cull, Javier Muñoz, Alessandra Tedeschi, Andrew W. Roberts, John F. Seymour, Siminder Atwal, Yiling Yu, William Novotny, Eric Holmgren, Ziwen Tan, James Hilger, Jane Huang, Constantine S. Tam
Published 2020Artigo -
17
Central nervous system involvement by Waldenström macroglobulinaemia (Bing‐Neel syndrome): a multi‐institutional retrospective study by Jorge J. Castillo, Shirley D’Sa, Michael P. Lunn, Monique C. Minnema, Alessandra Tedeschi, Frederick Lansigan, M. Lia Palomba, Marzia Varettoni, Ramón García‐Sánz, Lakshmi Nayak, Eudocia Q. Lee, Mikael L. Rinne, Andrew D. Norden, Irene M. Ghobrial, Steven P. Treon
Published 2015Artigo -
18
Report of consensus Panel 4 from the 11th International Workshop on Waldenstrom's macroglobulinemia on diagnostic and response criteria by Steven P. Treon, Alessandra Tedeschi, Jesús F. San Miguel, Ramón García‐Sánz, Kenneth C. Anderson, Eva Kimby, Monique C. Minnema, Giulia Benevolo, Lugui Qiu, Shuhui Yi, Evangelos Terpos, Constantine S. Tam, Jorge J. Castillo, Pierre Morel, Meletios Α. Dimopoulos, Roger G. Owen
Published 2023Artigo -
19
Phase 3 Trial of Ibrutinib plus Rituximab in Waldenström’s Macroglobulinemia by Meletios Α. Dimopoulos, Alessandra Tedeschi, Judith Trotman, Ramón García‐Sánz, D. Blair Macdonald, Véronique Leblond, Beatrice Mahé, Charles Herbaux, Constantine S. Tam, Lorella Orsucci, M. Lia Palomba, Jeffrey Matous, Chaim Shustik, Efstathios Kastritis, Steven P. Treon, Jianling Li, Zeena Salman, Thorsten Graef, Christian Buske
Published 2018Artigo -
20
Ibrutinib for the treatment of Bing-Neel syndrome: a multicenter study by Jorge J. Castillo, Gilad Itchaki, Jonas Paludo, Marzia Varettoni, Christian Buske, Toby A. Eyre, Julio C. Chávez, Kenneth H. Shain, Samar Issa, M. Lia Palomba, Oren Pasvolsky, David Simpson, Dipti Talaulikar, Constantine S. Tam, Alessandra Tedeschi, Stephen M. Ansell, Lakshmi Nayak, Steven P. Treon
Published 2018Artigo
Search Tools:
Related Subjects
Medicine
Internal medicine
Leukemia
Chronic lymphocytic leukemia
Oncology
Ibrutinib
Gastroenterology
Lymphoma
Chemotherapy
Adverse effect
Waldenstrom macroglobulinemia
Surgery
Immunology
Multiple myeloma
Neutropenia
Cyclophosphamide
Macroglobulinemia
Discontinuation
Rituximab
Clinical trial
Confidence interval
Hazard ratio
Environmental health
Population
Venetoclax
Chlorambucil
Clinical endpoint
Cohort
Fludarabine
IGHV@